As the de facto capital of Europe, and one of the most progressive cities on the planet, Berlin is poised to be the European leader in cannabis business and drug policy reform. In early 2017, Germany pushes forward with progressive medical marijuana regulations, and German private companies will soon be cultivating cannabis that will be supplied to patients through pharmacies. The economic and social ramifications of these recent decisions are profound. Join us at the Berlin ICBC and engross yourself in a vastly emerging market with endless potential. Must be 18 or older to attend this event.
We bring you the top speakers in the industry today. Visit our Speaker Page for full list of Berlin speakers.
Republican Congressman and champion of federal cannabis policy reform in the U.S.
Founder and chairman of the German Association for Cannabis as Medicine (ACM).
Creator of the TV show Weed Wars and Founder of Harborside Health Center in Oakland, California.
CEO and owner of the Deutscher Hanfverband (German Hemp Association).
One of the true legends of cannabis around the world.
Director of Marketing at Leafly.
Co-founded MedCann GmBH.
Co-founded Berkeley Patients Group.
8:30 Keynote with U.S. Congressman Dana Rohrabacher
Congressman Dana Rohrbacher (Republicans) heads the subcommittee on Foreign Affairs focused on Europe and Eurasia in the U.S. House of Representatives. The Californian representative is the co-initiator of the Rohrbacher-Farr resolution which was adopted in 2014. It prohibits the justice department to fund resources that interfere with the implementation of state medical marijuana laws.
9:15 International Medical Cannabis Policies
A comparative analyses of the world’s top medical cannabis models. Our experts will give insight to each’s respective system, go over the latest breakthroughs with each program, and discuss international cooperation concerning the import and export of medical cannabis.
10:15 Short Break
10:30 Medical Marijuana Rules and Regulations in Germany (Patients, Pharmacies and LPs)
The first licenses for the cultivation of medical cannabis will soon be given out by a federal cannabis agency. Also, acquiring your medical cannabis prescription will soon become a less cumbersome process for patients and doctors. We will delve into the process of becoming a German licensed producer, discuss the process of becoming a medical cannabis patient in Germany, as well as go over the pharmacies’ role as conduits between licensed producers and patients.
11:30 Extractions and Concentrates
Extractions are becoming a massive share of the market in the U.S. Currently, Germany’s medical cannabis patients only have access to flowers. Under the new German laws, extractions will be allowed to be sold in pharmacies. We will go over the most cutting edge, clean and efficient extraction methods and their alternate benefits and discuss how extractions will be implemented into the German market.
12:30 Lunch Break
1:30 Dr.Franjo Grotenhermen MD
It took patients 17 years to change the law in favor of medical cannabis. Dr.Franjo Grotenhermen is a MD and an internationally sought after cannabinoid-specialist, supporting Germany’s cannabis patients since over two decades. Dr.Grotenhermen will explain the basics of medical cannabis and its scientific background, while focusing on patients health and their right to safe and reliable medicine.
2:30 Testing and Standardization
From seed to sale, what are the best practices for standardizing cannabis for public consumption? Learn from testing models in other respective jurisdictions and experts on production as to what is currently working in terms of delivering a safe and contaminant free product to market.
3:30 Short Break
3:45 Entourage Effect
In its natural state, over 90% of cannabinoids produced by cannabis plants come in acidic forms. Acidic cannabinoids, such as cannabidiolic acid (CBDA), tetrahydrocannabinol acid (THCA), cannabigerolic acid (CBGA) and their functions remain largely overlooked. This talk will critically review experimental evidence of the therapeutic potential of acidic cannabinoids—as well as discuss the experimental and clinical evidence of the cannabis entourage effect—emphasizing the importance of the interactions between acidic and neutral phytocannabinoids, terpenes, and other compounds found in cannabis plants.
4:15 Celebrity Interview with Tommy Chong
It can’t all be business at the ICBC…interview conducted by Steve Bloom.
9:00 Keynote Speech
Stay tuned for more information!
9:45 Lobbying for Cannabis
It is no fluke that cannabis policy is changing around the world. Grassroots activists have been campaigning for fifty years to achieve the results we are currently seeing. Not only is advocating on the behalf of cannabis legalization the right thing to do, it is good practice for businesses in their respective communities. Our cannabis advocate experts will go over what steps it has taken to get to this point, as well as tips on future advocacy strategies and tactics.
10:45 Short Break
11:00 Cannabis and Media
Cannabis is a growingly hot topic in the media. The industry is beginning to boom worldwide and eighty years of prohibition is fading. As marijuana has become more mainstream, the media has adapted to reflect this new paradigm. Our panel of experts will provide a lay of the land for cannabis in the media, providing insight for business people and advocates of a landscape that continues to evolve and gain more acceptance across the globe.
12:00 Consumer Tech and Branding
Cannabis has gone mainstream, which means ratcheting up innovation and focusing on brand are crucial factors for success. Our panel features cannabis industry disrupters discussing the new competitive paradigm, with a focus on applicable German business models.
1:00 Lunch Break
2:00 Genetics: Globalization and Commercialization
As a growing number of countries legalize cannabis and set the groundwork for international commerce, the questions of plant breeders’ rights and Intellectual Property (IP) become paramount. Our panel will feature iconic breeders and leading legal minds examining the impact of global commercialization on plant genetics and IP.
3:00 Cannabis Cultivation and New Technologies
In the last 30 years, many innovations in the cultivation of cannabis have been developed. International commercial growers and producers will report the most efficient, smart and healthy ways to grow cannabis while considering scalability.
4:00 Public Markets Financing and Cannabis Stocks
With investor interest in cannabis at an all-time high, our panel will discuss the possibilities of public cannabis companies in Germany, as well as opportunities in more established areas as Canada. Our panel will include analysts along with COEs of cannabis pub-cos.
©2017 International Conferences Group, LLC | Site Design: VaporDave